3-keto-5β-Abiraterone Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
3-keto-5β-Abiraterone is a metabolite of abiraterone (A108490) which is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
3-keto-5β-Abiraterone Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte